| Home > Publications database > Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice. |
| Journal Article | DKFZ-2017-01975 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2016
ASCJ
Ann Arbor, Mich.
This record in other databases:

Please use a persistent id in citations: doi:10.1172/JCI83844
Abstract: Systemic inflammation causes malaise and general feelings of discomfort. This fundamental aspect of the sickness response reduces the quality of life for people suffering from chronic inflammatory diseases and is a nuisance during mild infections like common colds or the flu. To investigate how inflammation is perceived as unpleasant and causes negative affect, we used a behavioral test in which mice avoid an environment that they have learned to associate with inflammation-induced discomfort. Using a combination of cell-type–specific gene deletions, pharmacology, and chemogenetics, we found that systemic inflammation triggered aversion through MyD88-dependent activation of the brain endothelium followed by COX1-mediated cerebral prostaglandin E2 (PGE2) synthesis. Further, we showed that inflammation-induced PGE2 targeted EP1 receptors on striatal dopamine D1 receptor–expressing neurons and that this signaling sequence induced aversion through GABA-mediated inhibition of dopaminergic cells. Finally, we demonstrated that inflammation-induced aversion was not an indirect consequence of fever or anorexia but that it constituted an independent inflammatory symptom triggered by a unique molecular mechanism. Collectively, these findings demonstrate that PGE2-mediated modulation of the dopaminergic motivational circuitry is a key mechanism underlying the negative affect induced by inflammation.
Keyword(s): Membrane Proteins ; Receptors, Dopamine D1 ; Cyclooxygenase 1 ; Ptgs1 protein, mouse ; Dinoprostone
|
The record appears in these collections: |